Aldara™ Cream to treat basal cell carcinoma

Journal of Drugs in Dermatology, Oct, 2003

This study is currently recruiting patients.

Sponsored by Warren G Magnuson Clinical Center (CC)

This study will evaluate the effectiveness of Aldara (TM) (Imiquimod) Cream in treating basal cell carcinoma.

Condition              Treatment or Intervention          Phase

Basal Cell Carcinoma   Drug: Aldara[TM] (Imiquimod) Cream Phase IV

Study ID Numbers: 020289; 02-CC-0289 NLM Identifier: NCT00045851

COPYRIGHT 2003 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here

Content provided in partnership with Thompson Gale